MedicarePartD.guide

A non-government resource built from CMS public data

GVOKE HYPOPEN 1 MG AUTO-INJECTOR 1 mg/.2mL Injection, Solution

Also known as Glucagon Injection, Solution. Coverage in Hawaii (CMS PDP Region 33).

4 of 8 stand-alone Part D plans in Hawaii cover this drug on tier 3.

No plan applies a prior authorization, step therapy or quantity limit.

8 Medicare Advantage plans in HI do cover it

Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. HI: 8 plans.

Every plan that covers it

PlanTier30-day preferred90-day mailUnit costEst. 30-day fillRestrictions
AARP Medicare Rx Saver from UHC (PDP)$0.00/mo premium · $615.00 deductible3Preferred Brand16%16%$1697.3275—None
Wellcare Value Script (PDP)$21.60/mo premium · $615.00 deductible3Preferred Brand25%25%$1539.7339—None
Wellcare Classic (PDP)$21.70/mo premium · $615.00 deductible3Preferred Brand25%25%$1539.7339—None
AARP Medicare Rx Preferred from UHC (PDP)$139.20/mo premium · $130.00 deductible3Preferred Brand17%17%$1697.3275—None

Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.

See coverage in all 39 regions →